Nephraegis Therapeutics

0 followers

‌

Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).

Industries

Headquarters

Employees

Links

Org chart

CEO

Bryan F. Cox

Collapse

Chief Development officer

Chief Commercial Officer

This company has no teams yet

Merck

222 followers

Pfizer

498 followers

Orchid

1 follower

Amgen

221 followers

Garuda Therapeutics

4 followers

Johnson & Johnson

443 followers

Revvity

5 followers

CHDI Foundation

5 followers

Abbott

284 followers

Thermo Fisher Scientific

170 followers

Genentech

157 followers

Explore companies